↓ Skip to main content

Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy

Overview of attention for article published in Journal of Hematology & Oncology, September 2016
Altmetric Badge

Citations

dimensions_citation
21 Dimensions

Readers on

mendeley
87 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy
Published in
Journal of Hematology & Oncology, September 2016
DOI 10.1186/s13045-016-0328-4
Pubmed ID
Authors

Gregory S. Alexander, Joshua D. Palmer, Madalina Tuluc, Jianqing Lin, Adam P. Dicker, Voichita Bar-Ad, Larry A Harshyne, Jennifer Louie, Colette M. Shaw, D. Craig Hooper, Bo Lu

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 87 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 87 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 16 18%
Student > Master 14 16%
Student > Ph. D. Student 10 11%
Student > Doctoral Student 7 8%
Student > Bachelor 6 7%
Other 14 16%
Unknown 20 23%
Readers by discipline Count As %
Medicine and Dentistry 40 46%
Biochemistry, Genetics and Molecular Biology 6 7%
Nursing and Health Professions 3 3%
Agricultural and Biological Sciences 3 3%
Neuroscience 3 3%
Other 5 6%
Unknown 27 31%